404 related articles for article (PubMed ID: 18941129)
21. Is there one successful antithyroid regimen for Graves' disease?
Braverman LE
Lancet; 1996 Sep; 348(9029):697-8. PubMed ID: 8806285
[No Abstract] [Full Text] [Related]
22. A combined case of macroprolactinoma, growth hormone excess and Graves' disease.
Hussein Z; Tress B; Colman PG
Med J Malaysia; 2005 Jun; 60(2):232-6. PubMed ID: 16114168
[TBL] [Abstract][Full Text] [Related]
23. [The surgical treatment of Graves' disease].
de Ruijter SH; van Dalen T; Muller AF
Ned Tijdschr Geneeskd; 2006 Jun; 150(24):1321-5. PubMed ID: 16808361
[TBL] [Abstract][Full Text] [Related]
24. Outcome of Graves' thyrotoxicosis after antithyroid drug treatment.
Chiou SC; Houng HS; Li KL; Ghang TC; Lo SK; Sun RH; Huang YY; Hsu BR; Lin JD; Hunang BY
Changgeng Yi Xue Za Zhi; 1995 Dec; 18(4):305-14. PubMed ID: 8851978
[TBL] [Abstract][Full Text] [Related]
25. Hyperthyroidism.
Maji D
J Indian Med Assoc; 2006 Oct; 104(10):563-4, 566-7. PubMed ID: 17380820
[TBL] [Abstract][Full Text] [Related]
26. Rapid preparation of severe uncontrolled thyrotoxicosis due to Graves' disease with Iopanoic acid--a case report.
Pandey CK; Raza M; Dhiraaj S; Agarwal A; Singh PK
Can J Anaesth; 2004 Jan; 51(1):38-40. PubMed ID: 14709458
[TBL] [Abstract][Full Text] [Related]
27. Early treatment with low fixed dose (5 mCi) radioiodine therapy is effective in Indian subjects with Graves' disease.
Sanyal D; Mukhhopadhyay P; Pandit K; Chatterjee J; Raychaudhuri M; Mukherjee S; Chowdhury S
J Indian Med Assoc; 2008 Jun; 106(6):360-1, 372. PubMed ID: 18839646
[TBL] [Abstract][Full Text] [Related]
28. Azathioprine as an adjuvant therapy in severe Graves' disease: a randomized controlled open-label clinical trial.
Allam MM; El-Zawawy HT; Kader Okda AA; Ali Alshaikh A; Ghazy RM
Front Endocrinol (Lausanne); 2023; 14():1168936. PubMed ID: 37409226
[TBL] [Abstract][Full Text] [Related]
29. The adjunctive use of carbimazole during radioactive iodine treatment reduces the cure rate of Graves' disease.
Docrat F; Mokoena T; Karusseit VOL; Ankrah AO
S Afr Med J; 2021 Feb; 111(2):176-179. PubMed ID: 33944730
[TBL] [Abstract][Full Text] [Related]
30. Expression of thioredoxin in patients with Graves' disease.
Kihara M; Kontani K; Yamauchi A; Miyauchi A; Nakamura H; Yodoi J; Yokomise H
Int J Mol Med; 2005 May; 15(5):795-9. PubMed ID: 15806300
[TBL] [Abstract][Full Text] [Related]
31. Hyperthyroidism.
De Leo S; Lee SY; Braverman LE
Lancet; 2016 Aug; 388(10047):906-918. PubMed ID: 27038492
[TBL] [Abstract][Full Text] [Related]
32. A grave case of bradycardia.
Lee G; McGavigan AD; Hillock RJ; Roberts-Thomson KC; Stevenson IH; Mond HG
Pacing Clin Electrophysiol; 2006 Jul; 29(7):788-90. PubMed ID: 16884518
[TBL] [Abstract][Full Text] [Related]
33. Thyrotoxicosis presenting with headache.
Stone J; Foulkes A; Adamson K; Stevenson L; Al-Shahi Salman R
Cephalalgia; 2007 Jun; 27(6):561-2. PubMed ID: 17598793
[TBL] [Abstract][Full Text] [Related]
34. Graves' disease, thymus enlargement, and hypercalcemia.
Giovanella L; Suriano S; Ceriani L
N Engl J Med; 2008 Mar; 358(10):1078-9. PubMed ID: 18322294
[No Abstract] [Full Text] [Related]
35. Long-term outcome of thyrotoxicosis in childhood and adolescence in the west of Scotland: the case for long-term antithyroid treatment and the importance of initial counselling.
Kourime M; McGowan S; Al Towati M; Ahmed SF; Stewart G; Williamson S; Hunter I; Donaldson MDC
Arch Dis Child; 2018 Jul; 103(7):637-642. PubMed ID: 29269558
[TBL] [Abstract][Full Text] [Related]
36. Iodine distribution in thyroid tissue taken from hyperthyroid patients treated with Lugol's solution or carbimazole.
Etling N
Rev Eur Etud Clin Biol; 1971; 16(7):662-7. PubMed ID: 4107371
[No Abstract] [Full Text] [Related]
37. Investigational drugs in early stage clinical trials for thyrotoxicosis with hyperthyroidism.
Gómez-Sáez JM
Expert Opin Investig Drugs; 2018 Nov; 27(11):831-837. PubMed ID: 30354697
[TBL] [Abstract][Full Text] [Related]
38. Predicting the likelihood of remission in children with Graves' disease: a prospective, multicenter study.
Glaser NS; Styne DM;
Pediatrics; 2008 Mar; 121(3):e481-8. PubMed ID: 18267979
[TBL] [Abstract][Full Text] [Related]
39. [Determination of susceptibility to pharmacologic treatment in Graves'-Basedow disease].
Grzywa M; Maciejko-Meresta B
Pol Tyg Lek; 1991 Oct 28-Nov 4; 46(43-44):822-3. PubMed ID: 1726989
[TBL] [Abstract][Full Text] [Related]
40. [Recurrence of Graves-Basedow disease: the influence of treatment schedule].
Goñi Iriarte MJ; Forga Llenas L; Iriarte Beroiz A; Apiñániz EA; Rodríguez Erdozain R; Menéndez Torre E
Med Clin (Barc); 1995 Jan; 104(1):11-4. PubMed ID: 7877347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
